Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PfLSA-3-rec Malaria Vaccine Trial
NCT00509158Phase 2Completed
- Sponsor
- Radboud University Medical Center
- Start
- Oct 2007
- Primary completion
- Oct 2008
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of LSA-3-rec in malaria (2 arms), sponsored by Radboud University Medical Center. Primary endpoints: Proportion and severity of adverse events at 1 year and Proportion of volunteers reaching day 21 post-infection without or with a delayed onset of parasitemiae at 6 weeks. Started Oct 2007; status: completed.
02
Drugs
LSA-3-rec
03
Conditions
malaria
Beyond the preview
Go deeper on NCT00509158.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00509158.